# Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

> **NCT05330871** · PHASE2 · UNKNOWN · sponsor: **Seventh Medical Center of PLA General Hospital** · enrollment: 410 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** 1 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 2 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 3 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 4 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 5 Intramuscular injection for booster groups
- **BIOLOGICAL:** 6 Intramuscular injection for booster groups
- **BIOLOGICAL:** 7 Intramuscular injection for booster groups
- **BIOLOGICAL:** 8 Intramuscular injection for booster groups
- **BIOLOGICAL:** 9 Intramuscular injection for booster groups
- **BIOLOGICAL:** 10 Intramuscular injection for booster groups
- **BIOLOGICAL:** 11 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 12 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 13 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 14 Nebulized inhalation for booster groups
- **BIOLOGICAL:** 15 Intramuscular injection for booster groups
- **BIOLOGICAL:** 16 Intramuscular injection for booster groups
- **BIOLOGICAL:** 17 Intramuscular injection for booster groups
- **BIOLOGICAL:** 18 Intramuscular injection for booster groups
- **BIOLOGICAL:** 19 Intramuscular injection for booster groups
- **BIOLOGICAL:** 20 Intramuscular injection for booster groups

## Key facts

- **NCT ID:** NCT05330871
- **Lead sponsor:** Seventh Medical Center of PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-17
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05330871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05330871, "Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05330871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*